How do you know if a “positive” study is positive? And what if clinical trial participants unionized?
We discuss all that and more on the latest episode of “The Readout LOUD,” STAT’s biotech podcast. First, we dig into Biogen’s much-dissected data on a treatment for Alzheimer’s disease, with on-the-ground takes from experts at a scientific conference. Then, STAT’s Eric Boodman joins us to spin a drug-discovery yarn involving one-eyed sheep, Basque farmers, and the quest to treat a rare form of cancer.
And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].
Interested in sponsoring a future episode of “The Readout LOUD”? Email us at [email protected].